During the past trading week (February 3 to 7), a Canadian cannabis producer lost its longtime leader and announced cuts to improve profitability.

A battered cannabis firm took another major hit after a superior court allowed for a class-action lawsuit to be carried through, and a multimillion-dollar deal was finally closed after months of uncertainty.

Here’s a closer look at some of the biggest cannabis news over the week.

Aurora loses CEO, joins Tilray in cutting 10 percent of staff

Another well-known name in the Canadian cannabis industry has fallen, with Terry Booth, former CEO of Aurora Cannabis (NYSE:ACB,TSX:ACB), declaring his retirement after seven years at the helm.

The Thursday (February 6) announcement states that Aurora’s executive chairman, Michael Singer, will succeed Booth as interim CEO effective immediately, though Booth will still serve on the board.

Aurora’s board of directors is also welcoming two new players: Lance Friedmann and Michael Detlefsen.

In a call with analysts after market close on Thursday, Singer said the change has Booth’s full support and that the former CEO “recognizes that the next leg of our journey will be best led by a CEO with a different skill set.”

Aurora’s leadership change comes just a day after BNN Bloomberg reported the Alberta-based cannabis producer is planning to cut its workforce of about 3,400 employees by 10 percent.

With the announcement of Booth’s departure, the company also confirmed plans to bring its capital expenditures below C$100 million for the second half of the 2020 fiscal year amid a series of disappointing quarterly results.

Aurora expects impairment charges on certain intangible property, plants and equipment to cost from C$190 million to C$225 million. There will also be a goodwill writedown of up to C$775 million.

The company isn’t expecting much growth when it comes to revenue in the upcoming quarter. Due to industry headwinds, including a dip in international revenues and low bulk sales, the firm estimates little to no quarter-over-quarter change in Q2 2020, with revenue projections of C$62 million to C$66 million.

Singer also blamed a slow rollout of retail stores in key provinces, changes in the purchasing patterns of provincial distributors and shifting consumer preferences on the firm’s less-than-impressive gains.

“We believe our succession plan, expansion of the board and the rationalization of our business will make Aurora much stronger and more focused than ever before,” Singer said.

Along with Aurora, Tilray (NASDAQ:TLRY) also announced plans to downsize its staff to reduce costs.

On Tuesday (February 4), the British Columbia-based company told news outlets that it is cutting 10 percent of its staff to reach its profitability goals.

In a statement to the Financial Post, Brendan Kennedy, CEO of Tilray, said the decision to cut its staff of over 1,400 employees wasn’t taken lightly.

“By reducing headcount and cost, Tilray will be better positioned to achieve profitability,” Kennedy said.

Since the announcement, Aurora’s share price has fallen 17.4 percent from market close on Thursday to market open on Friday (February 7). Tilray fared a bit better, dropping only 1.8 percent from the start of the trading session on Tuesday to market open on Friday.

Aurora and Tilray’s woes are just some in a recent group of losses and departures that have plagued the marijuana industry in the past weeks.

Both Sundial Growers (NASDAQ:SNDL) and MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF) lost their respective leaders last week. Earlier in the year, TerrAscend (CSE:TER,OTCQX:TRSSF) and The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) let go of their CEOs as well.

CannTrust faces class-action lawsuit

Beleaguered cannabis firm CannTrust Holdings (NYSE:CTST,TSX:TRST) is up against its newest challenge after the Ontario Superior Court of Justice confirmed that a team of Ontario-based law firms will be allowed to carry out a proposed securities class action against the firm.

On Monday (February 3), the law firms said the action was in connection to CannTrust’s failure to disclose the non-compliant cultivation of cannabis in some of its facilities. The breach was revealed last summer.

In the fallout, the firm lost some of its key members, including former CEO Peter Aceto and former Chairman Eric Paul, and had its cultivation and production license suspended.

More recently, in December, CannTrust was told it was on the brink of being delisted from the New York Stock Exchange as its share price slipped below the US$1 threshold that the exchange requires to remain an active lister.

CannTrust has lost a stunning 75 percent of its value in New York since the news of its illegal growing operations broke. As of 2:08 p.m. EST on Friday, it sat at US$0.93.

Market updates

Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) was one firm that got a win this past week when it closed its acquisition of Cura Partners, the owner of the Select brand.

The deal’s end has been a long time coming as it was first announced in May of last year. Curaleaf’s deal did spend some time under the eye of antitrust regulators due to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

With Cura Partners’ assets, Curaleaf now has 53 dispensaries across the US in its portfolio.

The transaction was originally valued at US$948.8 million, but the firm told investors in October that it was amending the terms of the deal due to unfavorable market conditions.

Innovative Industrial Properties (NYSE:IIPR) announced a partnership with Illinois-based Green Thumb Industries (CSE:GTII,OTCQX:GTBIF), starting with a sale leaseback deal for a processing facility in Ohio.

Another real estate investor, the energy– and transportation-focused Power REIT (NYSEAMERICAN:PW), stepped into the cannabis space after purchasing two marijuana greenhouse properties in Southern Colorado for US$3.75 million.

While Power was moving into cannabis, marijuana producer Australis Capital (CSE:AUSA,OTC:AUSAF) branched out into fintech with the acquisition of Paytron, a payment service provider that specializes in secure processing and point-of-sale hardware, among other technologies.

Also in the US, iAnthus Capital Holdings (CSE:IAN,OTCQX:ITHUF) got the green light to begin its operations in New Jersey at its Pleasantville cultivation campus.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less


Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less